1,2,3,9-四氢咔唑-4-酮生产废液处理及氯化锌回收利用

1,2,3,9-四氢咔唑-4-酮生产废液量大且危害严重,本文探究了NaClO、H₂O₂氧化处理废液的效果及存在的问题,同时提出了高温碳化处理的新工艺路线。 实验结果表明,采用NaClO、H₂O₂氧化处理废液未能达到理想要求,且回收的固体色泽差、无催化活性。 而废液经143 ℃蒸馏、残留液500 ℃高温碳化处理40 min后回收的氯化锌,具有良好催化活性,可使单苯腙转化率达到52.6%,实现了其在1,2,3,9-四氢咔唑-4-酮生产过程中的循环利用 。研究结果为1,2,3,9-四氢咔唑-4-酮生产废液处理及资源综合利用提供了一条新途径。     

研磨法合成1,2,3,6-四氢嘧啶-2-酮衍生物

以NH₂SO₃H为催化剂, 室温无溶剂条件下, 研磨芳醛、β-酮酸酯和尿素合成了一系列1,2,3,6-四氢嘧啶-2-酮衍生物. 该方法具有反应条件温和、操作简便、环境友好、产率高等优点.     

4-取代-3-烷基-4,5-二氢-1-(3-氯-4-氟苯基)-1,2,4-三唑-5-酮的合成及生物活性

为寻找活性强、作用时间长的新型非肽类血管紧张素II AT₁受体拮抗剂, 从易得原料3-烷基-4,5-二氢-1-(3-氯-4-氟苯基)-1,2,4-三唑-5-酮出发, 经过N-烃化反应、1,3-偶极反应、氢解、水解和酰化等反应, 合成得到一系列4-取代-3-烷基-4,5-二氢-1-(3-氯-4-氟苯基)-1,2,4-三唑-5-酮类衍生物, 总收率为58%～87%, 其结构经IR, ¹H NMR, MS和元素分析确证. 初步药理试验结果表明: 所有目标化合物均有一定的AT₁受体拮抗活性, 其中化合物12d抑制AII诱导的兔主动脉环收缩的IC₅₀值为4.0×10^－9 mol/L, 与阳性药坎地沙坦(candesartan)相当, 具有进一步的研究意义.     

1-甲基-5,6,7,8-四氢异喹啉酮-4-甲胺的合成研究

以环己酮为起始原料,经缩合、酰化及酸性水解反应制得2 乙酰基环己酮（1）;在三乙烯二胺催化下,1与氰基乙酰胺环化得四氢异喹啉酮（2）和四氢喹啉酮（3）混合物,在乙醇中回流并趁热过滤进行分离纯化得2和3; 2经催化加氢反应合成1-甲基-5,6,7,8-四氢异喹啉酮-4-甲胺,3步总收率39.8%,其结构经¹H NMR、¹³C NMR、 ¹H-¹⁵N HMBC和MS确证。     

12-苯基取代四氢-β-咔啉二酮哌嗪的合成

以L-色氨酸甲酯盐酸盐为原料,经Pictet-Spengler反应,Schotten-Baumann反应,酰胺键形成及脱保护4步反应合成了12-苯基取代四氢-β-咔啉二酮哌嗪,其结构经1 H NMR,13C NMR,IR和元素分析表征.     

一步合成1,3,4-三芳基取代3,4,5,6-四氢嘧啶-2(1H)-酮衍生物

以芳基异氰酸酯(1)和β-芳胺基苯丙酮(2)为原料, 甲苯为溶剂, 在回流条件下一步有效地合成了1,3,4-三芳基取代3,4,5,6-四氢嘧啶-2(1H)-酮类化合物3, 并研究了反应条件对产率的影响. 结果表明, 该法具有操作简单、原料易得、反应收率高(79～96%)等优点.     

四氢喹啉-4-醇类衍生物的合成

以1,2,3,4-四氢喹啉为初始原料,经N-酰基保护、氧化、脱保护、还原等反应合成了一系列1,2,3,4-四氢喹啉-4-醇类的衍生物,总产率17%~41%,其结构经1H NMR和13C NMR确证。     

氯化锌催化合成3-取代-4(3H)-喹唑啉酮衍生物

室温、无溶剂条件下,氯化锌可有效催化邻氨基苯甲酸、原甲酸酯和胺三组分一锅法合成一系列3-取代-4(3H)-喹唑啉酮衍生物。考察了反应条件对产率的影响,确定优化反应条件为n酸:n酯:n胺=1∶1.2∶1.2,ZnCl21(mol)%。该方法条件温和,产率较高,操作简单,且对环境友好。产品结构经IR,1HNMR,元素分析进行表征。     

3-甲基-4-芳亚甲基-异噁唑-5(4H)-酮的合成

报道了以吡啶为缚酸剂, 由乙酰乙酸乙酯、盐酸羟胺和芳香醛经三组分一锅法缩合制备3-甲基-4-芳亚甲基-异噁唑-5(4H)-酮衍生物的新方法. 产物结构经MS, ¹H NMR和IR确证.     

Sc(OTf)_3/Bis(oxazoline)复合物催化的2-芳基-1,3-茚二酮与2-乙烯基吲哚的不对称Diels-Alder反应:高效构建四氢咔唑螺茚酮衍生物

报道了Sc(OTf)3/Bis(oxazoline)复合物催化的2-芳基-1,3-茚二酮与2-乙烯基吲哚的不对称Diels-Alder反应,简便、高效的构建了一系列手性四氢咔唑螺茚酮衍生物.通过考察不同的金属盐和手性配体、溶剂、温度等因素对反应的影响,获得了优良的收率(up to 92%yield)和优异的对映选择性(up to 94%ee).该反应条件温和,具有宽广的底物适用范围和较好的官能团兼容性.     

Synthesis and antiemetic activity of 1,2,3,9-tetrahydro-9-methyl-3-(4-substituted-piperazin-1-ylmethyl)-4H-carbazol-4-one derivatives

5-HT₃ receptor antagonists, such as Ondansetron, are used for anti-emesis after chemotherapy, radiotherapy and operations. Some Ondansetron analogs possessing piperazine ring as side chains were synthesized in our lab. Thus, one of the two carbonyl groups of starting material 1,3-cyclohexandione (1) was condensed with phenylhydrazine hydrochloride to form monophenylhydrazone (2). 1,2,3,9-Tetrahydro-4H-carbazol-4-one (3) was prepared from 2 via cyclization and rearranged in the presence of ZnCl₂. Through a methylation reaction, compound 3 was converted to 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one (4). 3-Dimethylaminomethyl substituted compound (5) was synthesized from 4 by a Mannich reaction in glacial acetic acid. Nine novel 1,2,3,9-tetrahydro-9-methyl-3-(4-substituted-piperazin-1-ylmethyl)-4H-carbazol-4-one derivatives (6a–6i) were synthesized through nucleophilic substitution reaction of 5 with piperazines. The structures of all the target compounds were determined by elemental analysis, IR, MS, ¹H NMR and ¹³C NMR spectra. The results of preliminary pharmacological test show that part of the novel compounds have antiemetic activity comparable to that of the control Ondansetron. __________ Translated from Chinese Journal of Organic Chemistry, 2008, 28(2) (in Chinese)     

用Heck反应合成1-羟基-4-(3-吡啶基)丁-2-酮

在Heck反应条件下,以Ph3P为催化剂配体,由3-卤代吡啶和3-丁烯-1,2-二醇进行偶合可以得到1-羟基-4-(3-吡啶基)丁-2-酮,具有原料易得、合成方法简单的优点.     

2-烷(芳)氧基苯并呋喃并[3,2-d]嘧啶-4(3H)-酮衍生物的合成及杀菌活性

应用膦亚胺3与芳基异氰酸酯的氮杂Wittig反应, 生成碳二亚胺4, 4再分别与酚、醇作用, 在碳酸钾或醇钠催化下关环, 以72%～88%的产率合成了2-烷(芳)氧基取代-苯并呋喃并[3,2-d]嘧啶-4(3H)-酮衍生物5和6, 其结构经IR, 1H NMR, MS和元素分析证实. 初步生物活性测试表明该类化合物表现出温和的杀菌活性. 如5f在50 mg/L浓度时, 对黄瓜灰霉菌的抑制率为55%.     

新型4,4-二甲基异噁唑-3-酮衍生物的合成及生物活性研究

以Baylis-Hillman加成物为起始原料,设计并合成了5个结构新颖的4,4-二甲基异唑-3-酮衍生物。所合成的化合物经IR、1HNMR和元素分析确证。生物活性测试结果表明,所合成的目标产物在2000gai/ha的剂量下均具有较好的除草活性。中间体1-(2,4-二氯苯基)-2-溴甲基丙烯酸乙酯具有杀虫活性,在600gai/ha的剂量下对朱砂叶螨防效为100%。     

Synthesis of Some Novel 5-(Arylidene)-2-imino-3(pyridin-2-yl)thiazolidin-4-one Derivatives

Treatment of 2-aminopyridine ( 1 ) with chloroacetyl chloride in dry benzene gave 2-chloro-N-(pyridin-2-yl)acetamide ( 3 ), which on further reaction with potassium thiocyanate gave 2-imino-3-(pyridin-2-yl)thiazolidin-4-one ( 4 ) as an intermediate compound for the synthesis of pyridin-2-yl substituted 2-imino-thiazolidine-4-one derivatives. Cyclocondensation reaction of ( 4 ) with a series of aromatic aldehydes gave 5-arylidene derivatives of pyridin-2-yl substituted 2-imino-thiazolidine-4-ones 5a–j . ¹ H and ¹³C NMR spectroscopy, as well as elemental analyses, were used for the identification of these new compounds.     

Synthesis of 1,7-Bis(4-hydroxyphenyl)-3-hydroxy-1,3-heptadien-5-one

l,7-Bis(4-hydroxyphenyl)-3-hydroxy-1,3-heptadien-5-oneIIwagfirstlyisolatedfromtheseedsofAIPiniablepharocalyxK.Schum.(Zingiberaceae)asanoveldiarylheptanoid.Meanwhile,l,7-his(4-hydroxyphenyl)-3-hydroxy-l,3,6-heptatTien-5-one2,aknowndiarylheptanoid,wasisolatedaswell.Therecentpublication'reportedthatIstronglyinhibitedtheaggregationofplateletinducedbycollagen,arachidonicacidandadenosinediphosphate.AdditionalresearchZprovedthat2couldactasaninhibitoroftheHIV-1integrase.Byourfindings,thesynthesi…     

Design,Synthesis, Inhibiting HDACs Ability and Antitumor Activity of Pyrimidin-4(3H)-one Hydroxamate Derivatives

A series of novel pyrimidin-4(3H)-one hydroxamate derivatives was designed, synthesized and studied for their activities against histone deacetylases(HDACs). The results indicate that all the compounds show HDACs inhibitiory activity. The antiproliferative activities of the compounds against HeLa and A549 cells were also investigated. The pharmacological results show compound 9g has potent activity in the enzymatic inhibition assay and cell-based assay.     

Heteroannulated Quinazoline and Quinazolinone Derivatives from (Z)-2-[1-Benzamido-2-(3,4,5-trimethoxyphenyl)]vinyl-3,1-benzoxazin-4(3H)-one

The title compound 1 was prepared and allowed to react with a series of nitrogen nucleophiles to afford the quinazoline and quinazolinone derivatives 2–12 and tetrazole derivative 13. The IR, ¹H NMR, ¹³C NMR, and mass spectra of all the synthesized compounds were discussed.     

新型2-氨基-呋喃并[2,3-d]嘧啶-4(3H)-酮衍生物的合成及抗肿瘤活性

报道应用aza-Wittig反应,采用易得的原料,在温和的条件下,以78%～90%的产率有效的合成了新型2-氨基-呋喃并[3,2-d]嘧啶-4(3H)-酮衍生物5,其结构经IR,1H NMR,MS和元素分析确认.为进一步得到结构确认,化合物5c经X射线衍射分析证实.运用噻唑蓝(MTT)标准法对化合物5进行了体外抗肿瘤活性的测定,其中5f对肺癌细胞A459的IC50值为18.4μmol/L,显示出潜在良好的抗肿瘤活性.